Weekly cases up 50% in Haryana, 26% in Delhi

NEW DELHI: Weekly Covid-19 cases continued to decline in the country but the fall was slowing down as the number of fresh cases inched up in Delhi, Haryana and Gujarat while a few other states showed signs of the Covid curve flattening.

However, deaths from the virus continued to fall sharply, with just around 54 fatalities recorded in the week ending Sunday (April 4-10), the lowest weekly toll in over two years since March 23-29, 2020, the week when a national lockdown was announced. Just a single Covid death was reported on Sunday (from Delhi) till late at night, with data from a few more states awaited.

Meanwhile, India reported around 7,100 new cases in the week, the lowest weekly tally in two years since April 6-12, 2020, when the number was below 5,000. Cases were down 15% as compared with the previous week, the lowest drop in weekly numbers since the third wave of the pandemic started receding in late January this year.

Delhi recorded a 26% rise in new cases during the week. The capital logged 943 cases, up from 751 in the previous seven days, reversing a declining trend in infections since the peak of the third wave. With testing numbers down, Delhi has been reporting daily positivity rates of more than 1% in the past several days. Neighbouring Haryana posted a higher rise in cases during the week. New infections were up nearly 50% from 344 in the previous week to 514.

In Gujarat, where daily cases have seen a minor spurt over the past three days, 115 fresh cases were recorded in the week. This was 89% higher than the previous week’s tally of 61. However, in all three states, the overall numbers remain low and the rise in cases could be a result of localised outbreaks.

Elsewhere, the decline in numbers was slowing down in Karnataka, which saw infections fall by 8%, Telangana (down 4%) and Maharashtra (12% decline).

Maharashtra posted 776 cases during the week as compared to 885 in the previous seven days. The state, however, reported 27 deaths from the virus during the week – half of the nationwide toll and a three-fold increase from nine fatalities logged in the previous week.

  • Related Posts

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital, Kengeri, Bengaluru, part of the Fortis Healthcare Network, marked World Organ Donation Day with its annual commemorative event, ‘A Legacy That Lives On.’ The event brought together…

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Punjab: The Narcotics Control Bureau (NCB) has uncovered an alleged pharmaceutical-drug diversion network operating through rural areas of Punjab. Investigators are tracing the movement of fentanyl and other drugs regulated…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    Gleneagles BGS Hospital honours donor families with India’s largest organ donation recognition wall

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    NCB Uncovers Pharmaceutical Fentanyl Diversion Racket in Rural Punjab; Over 18,000 NDPS Drug Units Seized

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Sun Pharma will Need HC Nod for Semaglutide Tablet Launch

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    Bombay HC tells Maharashtra FDA to be ‘judicious’ after Cadila challenges order to ban sale of some medicines

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    ‘Erring pharma companies’: Over 1,000 cough syrup manufacturers undergo intense audits

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses

    Maharashtra FDA permanently cancels Pune-based pharma firm’s license over six contaminated medicines, GMP lapses